Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration

Cell Transplantation

Volumn 20, Issue 11-12, 2011, Pages 1791-1803

  Sgroi, Antonino ^a,b   Mai, Gang ^a,b   Morel, Philippe ^a   Baertschiger, Reto M ^a   Gonelle Gispert, Carmen ^a   Serre Beinier, Véronique ^a   Buhler, Leo H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Acute liver failure; Encapsulation; Hepatocyte transplantation; Immortalized human hepatocytes; Liver regeneration; Xenotransplantation

Indexed keywords

INTERLEUKIN 6; LENTIVIRUS VECTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER FAILURE; ARTICLE; CELL ENCAPSULATION; CELL IMMORTALIZATION; CELL SURVIVAL; CELL TRANSPLANTATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; LIVER FUNCTION; LIVER METABOLISM; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; XENOTRANSPLANTATION;

ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CAPSULES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; INTERLEUKIN-6; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; SERUM ALBUMIN; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 79959751040     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X564976     Document Type: Article

References (43)

1. Ahmad, T. A.; Eguchi, S.; Yanaga, K.; Miyamoto, S.; Kamohara, Y.; Fujioka, H.; Furui, J.; Kanematsu, T. Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats. Cell Transplant. 11:399-402; 2002.
2. Ahmad, T. A.; Fujioka, H.; Eguchi, S.; Yanaga, K.; Kamohara, Y.; Furui, J.; Kanematsu, T. Long-term effect of hepatocyte transplantation on fulminant hepatic failure in rats. Hepatogastroenterology 50:467-471; 2003.
3. Andreoletti, M.; Loux, N.; Vons, C.; Nguyen, T. H.; Lorand, I.; Mahieu, D.; Simon, L.; Di Rico, V.; Vingert, B.; Chapman, J.; Briand, P.; Schwall, R.; Hamza, J.; Capron, F.; Bargy, F.; Franco, D.; Weber, A. Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: Implication for ex vivo gene therapy. Hum. Gene Ther. 12: 169-179; 2001.
4. Aoki, T.; Jin, Z.; Nishino, N.; Kato, H.; Shimizu, Y.; Niiya, T.; Murai, N.; Enami, Y.; Mitamura, K.; Koizumi, T.; Yasuda, D.; Izumida, Y.; Avital, I.; Umehara, Y.; Demetriou, A. A.; Rozga, J.; Kusano, M. Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. Transplantation 79:783-790; 2005.
5. Arkadopoulos, N.; Lilja, H.; Suh, K. S.; Demetriou, A. A.; Rozga, J. Intrasplenic transplantation of allogeneic hepa-tocytes prolongs survival in anhepatic rats. Hepatology 28:1365-1370; 1998.
6. Assy, N.; Minuk, G. Y. Liver regeneration: Methods for monitoring and their applications. J. Hepatol. 26:945-952; 1997.
7. Boess, F.; Kamber, M.; Romer, S.; Gasser, R.; Muller, D.; Albertini, S.; Suter, L. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: Possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73:386-402; 2003.
8. Bucher, P.; Morel, P.; Buhler, L. H. Xenotransplantation: An update on recent progress and future perspectives. Transpl. Int. 18:894-901; 2005.
9. David, B.; Dufresne, M.; Nagel, M. D.; Legallais, C. In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol. Prog. 20: 1204-1212; 2004.
10. Eguchi, S.; Lilja, H.; Hewitt, W. R.; Middleton, Y.; Demetriou, A. A.; Rozga, J. Loss and recovery of liver regeneration in rats with fulminant hepatic failure. J. Surg. Res. 72:112-122; 1997.
11. Fausto, N.; Campbell, J. S.; Riehle, K. J. Liver regeneration. Hepatology 43:S45-53; 2006.
12. Ferret, P. J.; Hammoud, R.; Tulliez, M.; Tran, A.; Trebe-den, H.; Jaffray, P.; Malassagne, B.; Calmus, Y.; Weill, B.; Batteux, F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures ac-etaminophen-induced acute liver failure in the mouse. Hepatology 33:1173-1180; 2001.
13. Fox, I. J.; Chowdhury, J. R.; Kaufman, S. S.; Goertzen, T. C.; Chowdhury, N. R.; Warkentin, P. I.; Dorko, K.; Sauter, B. V.; Strom, S. C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338:1422-1426; 1998.
14. Fox, I. J.; Roy-Chowdhury, J. Hepatocyte transplantation. J. Hepatol. 40:878-886; 2004.
15. Greene, A. K.; Puder, M. Partial hepatectomy in the mouse: Technique and perioperative management. J. Invest. Surg. 16:99-102; 2003.
16. He, Y.; Zhou, J.; Dou, K. F.; Chen, Y. A rat model for acute hepatic failure. Hepatobil. Pancreat. Dis. Int. 2:423-425; 2003.
17. Kobayashi, N.; Fujiwara, T.; Westerman, K. A.; Inoue, Y.; Sakaguchi, M.; Noguchi, H.; Miyazaki, M.; Cai, J.; Tanaka, N.; Fox, I. J.; Leboulch, P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287:1258-1262; 2000.
18. Kobayashi, N.; Miyazaki, M.; Fukaya, K.; Inoue, Y.; Sakaguchi, M.; Uemura, T.; Noguchi, H.; Kondo, A.; Tanaka, N.; Namba, M. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure. Transplantation 69:202-207; 2000.
19. Kobayashi, N.; Miyazaki, M.; Fukaya, K.; Noguchi, H.; Tanaka, N.; Namba, M. Intrasplenic transplantation of immortalized human fetal hepatocytes prolongs the survival of 90% hepatectomized rats. Transplant. Proc. 32:2365-2367; 2000.
20. Kobayashi, N.; Noguchi, H.; Westerman, K. A.; Wata-nabe, T.; Matsumura, T.; Totsugawa, T.; Fujiwara, T.; Leboulch, P.; Tanaka, N. Successful retroviral gene transfer of simian virus 40 T antigen and herpes simplex virus-thymidine kinase into human hepatocytes. Cell Transplant. 10:377-381; 2001.
21. Kobayashi, N.; Noguchi, H.; Westerman, K. A.; Wata-nabe, T.; Matsumura, T.; Totsugawa, T.; Fujiwara, T.; Leboulch, P.; Tanaka, N. Cre/loxP-based reversible immortalization of human hepatocytes. Cell Transplant. 10:383-386; 2001.
22. Kobayashi, N.; Westerman, K. A.; Taguchi, T.; Saka-guchi, M.; Fujiwara, T.; Urata, H.; Kishimoto, N.; Hay-ashi, N.; Nakaji, S.; Murakami, T.; Leboulch, P.; Tanaka, N. Expansion of human hepatocyte populations by a retro-viral gene transfer of simian virus 40 large T antigen. ASAIO J. 47:481-485; 2001.
23. Kobayashi, N.; Westerman, K. A.; Tanaka, N.; Fox, I. J.; Leboulch, P. A reversibly immortalized human hepatocyte cell line as a source of hepatocyte-based biological support. Addict. Biol. 6:293-300; 2001.
24. Kusano, M.; Mito, M. Observations on the fine structure of long-survived isolated hepatocytes inoculated into rat spleen. Gastroenterology 82:616-628; 1982.
25. Lee, S. W.; Wang, X.; Chowdhury, N. R.; Roy-Chowd-hury, J. Hepatocyte transplantation: State of the art and strategies for overcoming existing hurdles. Ann. Hepatol. 3:48-53; 2004.
26. Lee, W. M. Acute liver failure. N. Engl. J. Med. 329: 1862-1872; 1993.
27. Liu, J.; Pan, J.; Naik, S.; Santangini, H.; Trenkler, D.; Thompson, N.; Rifai, A.; Chowdhury, J. R.; Jauregui, H. O. Characterization and evaluation of detoxification functions of a nontumorigenic immortalized porcine hepa-tocyte cell line (HepLiu). Cell Transplant. 8:219-232; 1999.
28. Mai, G.; Nguyen, T. H.; Morel, P.; Mei, J.; Andres, A.; Bosco, D.; Baertschiger, R.; Toso, C.; Berney, T.; Majno, P.; Mentha, G.; Trono, D.; Buhler, L. H. Treatment of fulminant liver failure by transplantation of microencapsu-lated primary or immortalized xenogeneic hepatocytes. Xenotransplantation 12:457-464; 2005.
29. Matas, A. J.; Sutherland, D. E.; Steffes, M. W.; Mauer, S. M.; Sowe, A.; Simmons, R. L.; Najarian, J. S. Hepato-cellular transplantation for metabolic deficiencies: Decrease of plasms bilirubin in Gunn rats. Science 192:892-894; 1976.
30. Mathews, M. B.; Bernstein, R. M.; Franza, B. R.; Gar-rels, J. I. Identity of the proliferating cell nuclear antigen and cyclin. Nature 309:374-376; 1984.
31. Mei, J.; Sgroi, A.; Mai, G.; Baertschiger, R.; Gonelle-Gispert, C.; Serre-Beinier, V.; Morel, P.; Buhler, L. H. Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepato-cytes in mice. Cell Transplant. 18:101-110; 2009.
32. Nguyen, T. H.; Ferry, N. Liver gene therapy: Advances and hurdles. Gene Ther. 11(Suppl. 1):S76-84; 2004.
33. Nguyen, T. H.; Mai, G.; Villiger, P.; Oberholzer, J.; Salmon, P.; Morel, P.; Buhler, L.; Trono, D. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. J. Hepatol. 43:1031-1037; 2005.
34. Nguyen, T. H.; Oberholzer, J.; Birraux, J.; Majno, P.; Morel, P.; Trono, D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol. Ther. 6:199-209; 2002.
35. Rodriguez-Antona, C.; Donato, M. T.; Boobis, A.; Edwards, R. J.; Watts, P. S.; Castell, J. V.; Gomez-Lechon, M. J. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32:505-520; 2002.
36. Sgroi, A.; Serre-Beinier, V.; Morel, P.; Buhler, L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 87:457-466; 2009.
37. Stockmann, H. B.; IJzermans, J. N. Prospects for the temporary treatment of acute liver failure. Eur. J. Gastroent-erol. Hepatol. 14:195-203; 2002.
38. Strom, S. C.; Fisher, R. A.; Thompson, M. T.; Sanyal, A. J.; Cole, P. E.; Ham, J. M.; Posner, M. P. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559-569; 1997.
39. Suh, K. S.; Lilja, H.; Kamohara, Y.; Eguchi, S.; Arkado-poulos, N.; Neuman, T.; Demetriou, A. A.; Rozga, J. Bio-artificial liver treatment in rats with fulminant hepatic failure: Effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J. Surg. Res. 85:243-250; 1999.
40. Sutherland, D. E.; Numata, M.; Matas, A. J.; Simmons, R. L.; Najarian, J. S. Hepatocellular transplantation in acute liver failure. Surgery 82:124-132; 1977.
41. Totsugawa, T.; Yong, C.; Rivas-Carrillo, J. D.; Soto-Gutierrez, A.; Navarro-Alvarez, N.; Noguchi, H.; Okitsu, T.; Westerman, K. A.; Kohara, M.; Reth, M.; Tanaka, N.; Leboulch, P.; Kobayashi, N. Survival of liver failure pigs by transplantation of reversibly immortalized human hepa-tocytes with Tamoxifen-mediated self-recombination. J. Hepatol. 47:74-82; 2007.
42. Vons, C.; Loux, N.; Simon, L.; Mahieu-Caputo, D.; Dagher, I.; Andreoletti, M.; Borgnon, J.; Di Rico, V.; Bargy, F.; Capron, F.; Weber, A.; Franco, D. Transplantation of hepatocytes in nonhuman primates: A preclinical model for the treatment of hepatic metabolic diseases. Transplantation 72:811-818; 2001.
43. Walker, R. M.; Racz, W. J.; McElligott, T. F. Acetamino-phen-induced hepatotoxicity in mice. Lab. Invest. 42:181-189; 1980.